References
- Jemal A, Bray F, Center MM, et al. Global Cancer Statistics. CA Cancer J Clin. 2011; 61: 69–90.
- Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71: 209–49.
- Aleksandrova K, Pischon T, Jenab M, et al. Combined Impact of Healthy Lifestyle Factors on Colorectal Cancer: A Large European Cohort Study. BMC Med. 2014; 12(1): 1-15.
- Edge SB and Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC Cancer Staging Manual and the future of TNM. Ann Surg Oncol. 2010; 17: 1471-1474.
- Benson AB, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004; 22: 3408-3419.
- Argilés G, Tabernero J, Labianca R, et al. Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. Ann Oncol. 2020; 31(10): 1291-1305.
- Labianca R, Nordlinger B, Beretta GD, et al. Early Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. Ann Oncol. 2013; 24(Suppl 6): vi64-72.
- Marshall JL. Risk Assessment in Stage II Colorectal Cancer. Oncology (Williston Park). 2010; 24: 9-13.
- Lugli A, Karamitopoulou E and Zlobec I. Tumour Budding: A Promising Parameter in Colorectal Cancer. Br J Cancer. 2012; 106: 1713-1717.
- Mitrovic B, Schaeffer DF, Riddell RH, et al. Tumor Budding in Colorectal Carcinoma: Time to Take Notice. Mod Pathol. 2012; 25: 1315-1325.
- van Wyk HC, Park J, Roxburgh C, et al. The Role of Tumour Budding in Predicting Survival in Patients with Primary Operable Colorectal Cancer: A Systematic Review. Cancer Treat Rev. 2015; 41: 151-159.
- Lugli A, Kirsch R, Ajioka Y, et al. Recommendations for Reporting Tumor budding in Colorectal Cancer Based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017; 30(9): 1299-1311.
- Ueno H, Ishiguro M, Nakatani E, et al. Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results from the SACURA Trial. J Clin Oncol. 2019; 37(22): 1886–1894.
- Prall F. Tumour Budding in Colorectal Carcinoma. Histopathology. 2007; 50(1): 151-62 311.
- Rogers AC, Winter DC, Heeney A, et al. Systematic Review and Meta-analysis of the Impact of Tumour Budding in Colorectal Cancer. Br J Cancer. 2016; 115(7): 831-840.
- Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum. 1993; 36(7): 627-35.
- Roh MS, Lee JI, and Choi PJ. Tumor Budding as a Useful Prognostic Marker in Esophageal Squamous Cell Carcinoma. Dis Esophagus. 2004; 17(4): 333-337.
- Karamitopoulou E, Zlobec I, Born D, et al. Tumour Budding is a Strong and Independent Prognostic Factor in Pancreatic Cancer. Eur J Cancer. 2013; 49(5): 1032-1039.
- Liang F, Cao W, Wang Y, et al. The Prognostic Value of Tumor Budding in Invasive Breast Cancer. Pathol Res Pract. 2013; 209(5): 269-275.
- Luo WR, Gao F, Li SY, et al. Tumour Budding and the Expression of Cancer Stem Cell Marker Aldehyde Dehydrogenase 1 in Nasopharyngeal Carcinoma. Histopathology. 2012; 61(6): 1072-1081.
- Kadota K, Yeh YC, Villena-Vargas J, et al. Tumor budding correlates with the protumor immune microenvironment and is an independent prognostic factor for recurrence of stage I lung adenocarcinoma. Chest. 2015; 148(3): 711-721.
- Koyuncuoglu M, Okyay E, Saatli B, et al. Tumor Budding and E-Cadherin Expression in Endometrial Carcinoma: Are They Prognostic Factors in Endometrial Cancer? Gynecol Oncol. 2012; 125(1): 208-213.
- Saito K, Okuyama T, Miyazaki S, et al. Tumor budding as a predictive marker of relapse and survival in patients with stage II colon cancer. In vivo. 2022 Jul 1; 36(4): 1820-1828.
- Koelzer VH, Assarzadegan N, Dawson H, et al. Cytokeratin-based Assessment of Tumour Budding in Colorectal Cancer: Analysis in Stage II Patients and Prospective Diagnostic Experience. J Pathol Clin Res. 2017; 3(3): 171-178.
- Prall F, Ostwald C, and Linnebacher M. Tubular Invasion and the Morphogenesis of Tumor Budding in Colorectal Carcinoma. Hum Pathol. 2009; 40(10): 1510-1512.
- Prall F, Nizze H, and Barten M. Tumour Budding as Prognostic Factor in Stage I/II Colorectal Carcinoma. Histopathology. 2005; 47(1): 17-24.
- Basile D, Broudin C, Emile JF, et al. Tumor Budding is an Independent Prognostic Factor in Stage III Colon Cancer Patients: A Post-hoc Analysis of the IDEA-France Phase III Trial (PRODIGE-GERCOR). Ann Oncol. 2022; 33(6): 628-637.
- Ueno H, Murphy J, Jass JR, et al. Tumour ‘Budding’ as an Index to Estimate the Potential of Aggressiveness in Rectal Cancer. Histopathology. 2002; 40: 127-132.
- Graham RP, Vierkant RA, Tillmans LS, et al. Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort. Am J Surg Pathol. 2015; 39: 1340-1346.
- Smit M, van Pelt G, Roodvoets A, et al. Uniform noting for international application of the tumor-stroma ratio as an easy diagnostic tool: protocol for a multicenter prospective cohort study. JMIR Res 2019; Protoc 8: e13464. https://doi.org/10.2196/13464
- Smit M vPG, Tollenaar R, Mesker W Uniform noting for international application of the tumour-stroma ratio as easy diagnostic tool (UNITED) study website. http://watchstroma.com/. Accessed 27 July 2020
- Marloes AS, Gabi W van P, Valeska T, et al. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study. Intern J Colorectal Disease (2021) 36:2729–2737